Bridgewater Wealth & Financial Management LLC boosted its position in HCP, Inc. (NYSE:HCP) by 1.1% during the second quarter, according to its most recent disclosure with the SEC. The firm owned 52,693 shares of the real estate investment trust’s stock after buying an additional 556 shares during the period. Bridgewater Wealth & Financial Management LLC’s holdings in HCP were worth $1,684,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the company. Toronto Dominion Bank boosted its stake in shares of HCP by 56.7% in the first quarter. Toronto Dominion Bank now owns 126,366 shares of the real estate investment trust’s stock worth $3,952,000 after buying an additional 45,734 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of HCP by 24.9% in the first quarter. Ameriprise Financial Inc. now owns 742,597 shares of the real estate investment trust’s stock worth $23,230,000 after buying an additional 147,812 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its stake in shares of HCP by 3.0% in the first quarter. Schwab Charles Investment Management Inc. now owns 3,697,204 shares of the real estate investment trust’s stock worth $115,649,000 after buying an additional 108,805 shares during the last quarter. Dubuque Bank & Trust Co. boosted its stake in shares of HCP by 64.3% in the first quarter. Dubuque Bank & Trust Co. now owns 14,533 shares of the real estate investment trust’s stock worth $455,000 after buying an additional 5,685 shares during the last quarter. Finally, IFP Advisors Inc boosted its stake in shares of HCP by 9.5% in the first quarter. IFP Advisors Inc now owns 62,990 shares of the real estate investment trust’s stock worth $1,970,000 after buying an additional 5,479 shares during the last quarter. Institutional investors and hedge funds own 88.87% of the company’s stock.

HCP, Inc. (NYSE HCP) opened at 29.38 on Thursday. HCP, Inc. has a 1-year low of $27.61 and a 1-year high of $40.43. The company’s 50-day moving average is $31.02 and its 200 day moving average is $31.25. The firm has a market capitalization of $13.78 billion, a PE ratio of 20.03 and a beta of 0.37.

HCP (NYSE:HCP) last posted its quarterly earnings data on Tuesday, August 1st. The real estate investment trust reported $0.48 EPS for the quarter, topping the Zacks’ consensus estimate of $0.47 by $0.01. The company had revenue of $458.90 million for the quarter, compared to analyst estimates of $456.29 million. HCP had a return on equity of 9.96% and a net margin of 32.16%. The firm’s quarterly revenue was down 14.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.71 earnings per share. On average, equities analysts expect that HCP, Inc. will post $1.36 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 22nd. Investors of record on Monday, August 7th will be paid a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.04%. The ex-dividend date is Thursday, August 3rd. HCP’s dividend payout ratio is currently 102.07%.

ILLEGAL ACTIVITY NOTICE: “Bridgewater Wealth & Financial Management LLC Has $1.68 Million Stake in HCP, Inc. (HCP)” was first published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/17/bridgewater-wealth-financial-management-llc-has-1-68-million-stake-in-hcp-inc-hcp.html.

HCP has been the subject of a number of analyst reports. Jefferies Group LLC restated a “hold” rating and issued a $33.00 price objective on shares of HCP in a research note on Tuesday, July 25th. Zacks Investment Research cut shares of HCP from a “hold” rating to a “sell” rating in a research note on Tuesday, July 18th. Mitsubishi UFJ Financial Group initiated coverage on shares of HCP in a research note on Friday, April 21st. They issued a “hold” rating and a $32.00 price objective for the company. Royal Bank Of Canada restated a “hold” rating and issued a $31.00 price objective on shares of HCP in a research note on Wednesday, July 5th. Finally, Raymond James Financial, Inc. upgraded shares of HCP from an “underperform” rating to an “outperform” rating and set a $35.00 price objective for the company in a research note on Wednesday, June 14th. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $33.42.

In related news, insider Thomas Klaritch sold 2,651 shares of HCP stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the transaction, the insider now directly owns 176,830 shares of the company’s stock, valued at $5,575,449.90. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.22% of the stock is owned by insiders.

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.